Skip to main content
Bioton S.A. logo

Bioton S.A. — Investor Relations & Filings

Ticker · BIO ISIN · PLBIOTN00029 LEI · 259400I5R1L3OPCGII81 WAR Manufacturing
Open in API
Filings indexed 697 across all filing types
Latest filing 2016-04-29 Annual Report
Country PL Poland
Listing WAR BIO

About Bioton S.A.

https://bioton.com/en/

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Recent filings

Filing Released Lang Actions
Opinia i raport Deloitte Polska Spółka z ograniczoną odpowiedzialnością Sp.k. z badania sprawozdania finansowego Grupy Kapitałowej BIOTON S.A.
Annual Report Classification · 95% confidence The document is a comprehensive 'Consolidated Financial Statement' (Skonsolidowane Sprawozdanie Finansowe) for the fiscal year 2015, including the Independent Auditor's Report (Opinia Niezależnego Biegłego Rewidenta) and the Management Report (Sprawozdanie z Działalności). It contains detailed financial statements (balance sheet, income statement, cash flow) and audit findings. While it includes an audit report, the document is the full annual financial package for the group, which aligns with the definition of an Annual Report (10-K) in the context of global corporate filings. FY 2015
2016-04-29 Polish
Sprawozdanie Zarządu BIOTON S.A. z działalności Grupy Kapitałowej BIOTON S.A.
Management Reports Classification · 95% confidence The document is a 'Sprawozdanie Zarządu' (Management Report) for BIOTON S.A. covering the fiscal year 2015. It contains detailed management commentary, financial analysis, risk factors, and operational disclosures. While it references financial statements, it is primarily the management's narrative and analysis of the company's performance, which aligns with the definition of a Management Report (MDA). FY 2015
2016-04-29 Polish
Sprawozdanie finansowe Grupy Kapitałowej BIOTON S.A.
Annual Report Classification · 100% confidence The document is a comprehensive 'Consolidated Financial Statement' (Skonsolidowane sprawozdanie finansowe) for the fiscal year ending December 31, 2015, for the BIOTON S.A. Capital Group. It includes a table of contents, consolidated balance sheets, income statements, cash flow statements, and detailed notes on subsidiaries. Since it covers a full fiscal year and contains substantive financial statements, it is classified as an Annual Report (10-K). FY 2015
2016-04-29 Polish
Pismo Zarządu BIOTON S.A.
Audit Report / Information Classification · 95% confidence The document explicitly states: "Przekazujemy na Państwa ręce sprawozdania finansowe BIOTON S.A. ... za 2015 rok." (We present to you the financial statements of BIOTON S.A. ... for the year 2015.) It discusses detailed financial results, revenue figures, operational profit, and significant accounting adjustments (impairments/write-downs) for the full fiscal year 2015. This content strongly indicates a comprehensive annual financial report. Although it is presented as a letter from management, the core subject is the full-year financial statements. Since the text is substantial and contains the actual financial performance summary for the year, it is classified as an Annual Report (10-K), which often includes a management discussion section, rather than just an Earnings Release (ER) or a Report Publication Announcement (RPA). Given the context of Polish reporting standards, 10-K is the closest equivalent for a full annual financial report. FY 2015
2016-04-29 Polish
Opinia i raport Deloitte Polska Spółka z ograniczoną odpowiedzialnością Sp.k. z badania sprawozdania finansowego BIOTON S.A.
Audit Report / Information Classification · 95% confidence The document is an 'Independent Auditor's Report' (Opinia Niezależnego Biegłego Rewidenta) for Bioton S.A. for the fiscal year 2015. It includes the audit opinion, the scope of the audit, and general information about the company's financial statements. While it references the financial statements, it is a standalone audit report document rather than the full 10-K annual report itself. According to the filing definitions, standalone audit reports and results of internal/regulatory audits fall under the 'AR' category. FY 2015
2016-04-29 Polish
Sprawozdanie Zarządu BIOTON S.A. z działalności BIOTON S.A.
Management Reports Classification · 95% confidence The document is a 'Sprawozdanie Zarządu' (Management Board Report) for BIOTON S.A. covering the fiscal year 2015. It contains detailed management commentary, financial analysis, risk assessments, and operational disclosures required for an annual reporting cycle. While it is a management report, it serves as the core narrative component of the annual reporting package, which in the context of the provided definitions, aligns best with the Management Reports (MDA) category as it provides the detailed explanation of financial results, business trends, and outlook. FY 2015
2016-04-29 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.